Citation: | ZENG Ye, ZHOU Zixuan, SUN Xun. Preparation of sheddable PEG modified miRNA-complexing nanoparticles and its preliminary in vitro and in vivo study[J]. Journal of China Pharmaceutical University, 2016, 47(6): 702-707. DOI: 10.11665/j.issn.1000-5048.20160612 |
[1] |
Bartel DP.MicroRNAs:target recognition and regulatory functions[J].Cell,2009,136(2):215-233.
|
[2] |
Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way[J].Cell,2009,136(4):586-591.
|
[3] |
Zhu L,Mahato RI.Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation[J].Bioconjug Chem,2010,21(11):2119-2127.
|
[4] |
Li FY,Zhou JP,Wu XM,et al.Formula optimization and transfection efficiency of polyethyleneimine/DNA complexes[J].J China Pharm Univ(中国药科大学学报),2010,41(1):40-44.
|
[5] |
Dash PR, Read ML, Barrett LB, et al. Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery [J].Gene Ther,1999,6(4):643-650.
|
[6] |
Caplen NJ.Gene therapy progress and prospects.Downregulating gene expression:the impact of RNA interference [J].Gene Ther,2004,11(16):1241-1248.
|
[7] |
Vile RG,Russell SJ,Lemoine NR.Cancer gene therapy:hard lessons and new courses [J].Gene Ther,2000,7(7):2-8.
|
[8] |
Li YH,Zong L,Zhu JB,et al.Formulation optimization of PEGylated cationic liposomes as siRNA delivery system [J].J China Pharm Univ(中国药科大学学报),2011,42(5):412-417.
|
[9] |
Mishra S, Webster P, Davis ME, et al. PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles [J].Eur J Cell Biol,2004,83(3):97-111.
|
[10] |
Pun SH,Bellocq NC,Liu A,et al.Cyclodextrin-modified polyethylenimine polymers for gene delivery [J].Bioconjug Chem,2004,15(4):831-840.
|
[11] |
Larsen KL,Endo T,Ueda H,et al.Inclusion complex formation constants of α-,β-,γ-,δ-,ε-,ζ-,η- and θ-cyclodextrins determined with capillary zone electrophoresis [J].Carbohydr Res,1998,309(309):153-159.
|
[1] | YANG Chengwei, GUO Yali, LI Caolong. Synthesis and antibacterial activity of water-soluble limonin benzoylhydrazone derivatives[J]. Journal of China Pharmaceutical University, 2022, 53(3): 273-277. DOI: 10.11665/j.issn.1000-5048.20220303 |
[2] | GAO Liuzhou, XIE Yusuo, HUANG Wenlong, HU Guoqiang. Synthesis, antibacterial and antitumor activities of 1-cycloproyl-6-fluoro-7-(hydrazone)-quinolin-4(1H)-one-carboxylic acids[J]. Journal of China Pharmaceutical University, 2014, 45(6): 662-664. DOI: 10.11665/j.issn.1000-5048.20140607 |
[3] | PANG Daorui, LIU Fan, SHI Ying, LIU Jun, SHEN Weizhi, ZOU Yuxiao, LIAO Sentai, XIAO Gengsheng. Antibacterial activity of 10 phenolic compounds from mulberry[J]. Journal of China Pharmaceutical University, 2014, 45(2): 221-226. DOI: 10.11665/j.issn.1000-5048.20140216 |
[4] | HU Guo-qiang, HOU Li-li, WANG Guo-qiang, DUAN Nan-nan, WEN Xiao-yi, CAO Tie-yao, HUANG Wen-long. Synthesis and antitumor and antibacterial activities of fluoroquinolone C-3 isosteres I.norfloxacin C-3 carbonylhydrazone derivatives[J]. Journal of China Pharmaceutical University, 2012, 43(4): 298-301. |
[5] | CHEN Guo-hua, REN Zhong, YANG Yang, WU Fei-hua. Synthesis and antibacterial activity of novel fourth-generation cephalosporin compounds[J]. Journal of China Pharmaceutical University, 2009, 40(5): 395-399. |
[6] | Synthesis and Antibacterial Activity of C-2 Sulfur-Bridged Tetracyclofluoroquinolone Antibacterial Agent W1[J]. Journal of China Pharmaceutical University, 2001, (4): 7-11. |
[7] | In vitro and In vivo Antibacterial Activities of Fleroxacin Injection[J]. Journal of China Pharmaceutical University, 1997, (5): 53-57. |
[8] | Synthesis and Antibacterial Activity of 6, 8-Difluoro Quinolones[J]. Journal of China Pharmaceutical University, 1993, (5): 264-268. |
[9] | Antimicrobial Activity (in Vitro) of the Constituents of Bulbus Fritillariae[J]. Journal of China Pharmaceutical University, 1992, (3): 188-189. |
[10] | Fang Jingxian, Song Yirong, Bao Yongming. ANTIBACTERIAL ACTIVITIES OF DOXYCYCLINE AND TMP IN COMBINATION[J]. Journal of China Pharmaceutical University, 1984, (3): 54-60. |